4.7 Article

Reconsideration of Maternal Serological Testing for Predicting Congenital CMV Infection

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study

Yue Huang et al.

Summary: This study investigated the protective effect of maternal immunity against congenital cytomegalovirus (cCMV) infection. The results showed that a higher level of CMV IgG in early gestation was associated with a lower risk of cCMV infection in newborns, but this association was not observed in middle or late gestation.

EBIOMEDICINE (2022)

Article Virology

Dynamics of IgG-avidity and antibody levels after Covid-19

Emma Lofstrom et al.

Summary: In this study, the maturation of IgG avidity and antibody levels over time in patients with PCR-confirmed non-severe Covid-19 was investigated. The results showed a significant increase in total n-antibodies from 1 to 3 months post-infection, followed by a significant decrease from 3 to 6 months. Meanwhile, a decrease in IgG anti-spike levels and an increase in IgG-avidity index were observed, suggesting a potential aspect of long-term immunity post Covid-19.

JOURNAL OF CLINICAL VIROLOGY (2021)

Article Immunology

Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population

Yue Huang et al.

Summary: In China, the prevalence of CMV infection is high among pregnant women, while the prevalence of congenital CMV infection is relatively low. The majority of cCMV-positive newborns are born to mothers who are CMV seropositive.

EMERGING MICROBES & INFECTIONS (2021)

Article Health Care Sciences & Services

Comparison of detection strategies for screening and confirming congenital cytomegalovirus infection in newborns in a highly seroprevalent population: a mother-child cohort study

Yue Huang et al.

Summary: This study found that saliva screening with saliva and urine confirmation showed good diagnostic accuracy and feasibility for cCMV infection screening. It is recommended to screen within 13 (ideally 5) days of birth and confirm within 21 (ideally 13) days of birth.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2021)

Article Immunology

Congenital Cytomegalovirus Infection: Prognostic Value of Maternal DNAemia at Amniocentesis

Giuliana Simonazzi et al.

CLINICAL INFECTIOUS DISEASES (2017)

Review Immunology

Role of Cytomegalovirus (CMV) IgG Avidity Testing in Diagnosing Primary CMV Infection during Pregnancy

Harry E. Prince et al.

CLINICAL AND VACCINE IMMUNOLOGY (2014)

Review Microbiology

The Silent Global Burden of Congenital Cytomegalovirus

Sheetal Manicklal et al.

CLINICAL MICROBIOLOGY REVIEWS (2013)

Editorial Material Immunology

Attribution of Congenital Cytomegalovirus Infection to Primary Versus Non-Primary Maternal Infection

Chengbin Wang et al.

CLINICAL INFECTIOUS DISEASES (2011)

Article Infectious Diseases

Incidence of cytomegalovirus infection among the general population and pregnant women in the United States

Fernando A. B. Colugnati et al.

BMC INFECTIOUS DISEASES (2007)